Global Point-of-Care Testing (POCT) Market Analysis and Forecast 2024-2030
Point-of-care (POC) is defined as medical testing at or near the site of patient care. The driving notion behind POCT is to bring the test conveniently and immediately to the patient. This increases the likelihood that the patient, physician, and care team will receive the results quicker, which allows for immediate clinical management decisions to be made.
According to APO Research, The global Point-of-Care Testing (POCT) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Point-of-Care Testing (POCT), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Point-of-Care Testing (POCT), also provides the sales of main regions and countries. Of the upcoming market potential for Point-of-Care Testing (POCT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Point-of-Care Testing (POCT) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Point-of-Care Testing (POCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Point-of-Care Testing (POCT) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc.
Point-of-Care Testing (POCT) segment by Company
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Point-of-Care Testing (POCT) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point-of-Care Testing (POCT) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
According to APO Research, The global Point-of-Care Testing (POCT) market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Global Point-of-Care Testing (POCT) main players are Roche, Abbott, Johnson & Johnson, etc. Global top three manufacturers hold a share over 45%. North America is the largest market, with a share nearly 40%.
This report presents an overview of global market for Point-of-Care Testing (POCT), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Point-of-Care Testing (POCT), also provides the sales of main regions and countries. Of the upcoming market potential for Point-of-Care Testing (POCT), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Point-of-Care Testing (POCT) sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Point-of-Care Testing (POCT) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Point-of-Care Testing (POCT) sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Roche, Abbott, Johnson & Johnson, Siemens Healthcare, Danaher, Ascensia, Bio-Rad Laboratories, BioMerieux and ARKRAY, etc.
Point-of-Care Testing (POCT) segment by Company
- Roche
- Abbott
- Johnson & Johnson
- Siemens Healthcare
- Danaher
- Ascensia
- Bio-Rad Laboratories
- BioMerieux
- ARKRAY
- Nova Biomedical
- Trividia Health
- Quidel
- Accriva
- OraSure Technologies
- Helena Laboratories
- A. Menarini Diagnostics
- Abaxis (Zoetis)
- Ortho Clinical Diagnostics
- Phamatech
- Chembio Diagnostics
- Trinity Biotech
- ELITech Group
- Response Biomedical
- Princeton BioMeditech
- Alfa Wassermann
- Blood Glucose Testing
- Infectious Diseases Testing
- Cardiac Markers Testing
- Coagulation Testing
- Pregnancy and Fertility Testing
- Blood Gas/Electrolytes Testing
- Urinalysis Testing
- Clinics
- Hospitals
- Laboratory
- Others
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Point-of-Care Testing (POCT) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Point-of-Care Testing (POCT) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Point-of-Care Testing (POCT).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Point-of-Care Testing (POCT) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Point-of-Care Testing (POCT) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Point-of-Care Testing (POCT) sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
Chapter 14: The main concluding insights of the report.
1 MARKET OVERVIEW
1.1 Product Definition
1.2 Point-of-Care Testing (POCT) Market by Type
1.2.1 Global Point-of-Care Testing (POCT) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.3 Point-of-Care Testing (POCT) Market by Application
1.3.1 Global Point-of-Care Testing (POCT) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 POINT-OF-CARE TESTING (POCT) MARKET DYNAMICS
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Point-of-Care Testing (POCT) Revenue Estimates and Forecasts (2019-2030)
3.2 Global Point-of-Care Testing (POCT) Revenue by Region
3.2.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Point-of-Care Testing (POCT) Revenue by Region (2019-2024)
3.2.3 Global Point-of-Care Testing (POCT) Revenue by Region (2025-2030)
3.2.4 Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2019-2030)
3.3 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts 2019-2030
3.4 Global Point-of-Care Testing (POCT) Sales by Region
3.4.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Point-of-Care Testing (POCT) Sales by Region (2019-2024)
3.4.3 Global Point-of-Care Testing (POCT) Sales by Region (2025-2030)
3.4.4 Global Point-of-Care Testing (POCT) Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers
4.1.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers (2019-2024)
4.1.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Point-of-Care Testing (POCT) Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Point-of-Care Testing (POCT) Sales by Manufacturers
4.2.1 Global Point-of-Care Testing (POCT) Sales by Manufacturers (2019-2024)
4.2.2 Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Point-of-Care Testing (POCT) Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Point-of-Care Testing (POCT) Sales Price by Manufacturers (2019-2024)
4.4 Global Point-of-Care Testing (POCT) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application
4.7 Global Point-of-Care Testing (POCT) Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
4.8.2 2023 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier
5 POINT-OF-CARE TESTING (POCT) MARKET BY TYPE
5.1 Global Point-of-Care Testing (POCT) Revenue by Type
5.1.1 Global Point-of-Care Testing (POCT) Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Point-of-Care Testing (POCT) Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2019-2030)
5.2 Global Point-of-Care Testing (POCT) Sales by Type
5.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030) & (M Units)
5.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2019-2030)
5.3 Global Point-of-Care Testing (POCT) Price by Type
6 POINT-OF-CARE TESTING (POCT) MARKET BY APPLICATION
6.1 Global Point-of-Care Testing (POCT) Revenue by Application
6.1.1 Global Point-of-Care Testing (POCT) Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Point-of-Care Testing (POCT) Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2019-2030)
6.2 Global Point-of-Care Testing (POCT) Sales by Application
6.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030) & (M Units)
6.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2019-2030)
6.3 Global Point-of-Care Testing (POCT) Price by Application
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
7.1.5 Roche Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
7.2.5 Abbott Recent Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Comapny Information
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
7.3.5 Johnson & Johnson Recent Developments
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Comapny Information
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
7.4.5 Siemens Healthcare Recent Developments
7.5 Danaher
7.5.1 Danaher Comapny Information
7.5.2 Danaher Business Overview
7.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
7.5.5 Danaher Recent Developments
7.6 Ascensia
7.6.1 Ascensia Comapny Information
7.6.2 Ascensia Business Overview
7.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
7.6.5 Ascensia Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Comapny Information
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 BioMerieux
7.8.1 BioMerieux Comapny Information
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
7.8.5 BioMerieux Recent Developments
7.9 ARKRAY
7.9.1 ARKRAY Comapny Information
7.9.2 ARKRAY Business Overview
7.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
7.9.5 ARKRAY Recent Developments
7.10 Nova Biomedical
7.10.1 Nova Biomedical Comapny Information
7.10.2 Nova Biomedical Business Overview
7.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
7.10.5 Nova Biomedical Recent Developments
7.11 Trividia Health
7.11.1 Trividia Health Comapny Information
7.11.2 Trividia Health Business Overview
7.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
7.11.5 Trividia Health Recent Developments
7.12 Quidel
7.12.1 Quidel Comapny Information
7.12.2 Quidel Business Overview
7.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
7.12.5 Quidel Recent Developments
7.13 Accriva
7.13.1 Accriva Comapny Information
7.13.2 Accriva Business Overview
7.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
7.13.5 Accriva Recent Developments
7.14 OraSure Technologies
7.14.1 OraSure Technologies Comapny Information
7.14.2 OraSure Technologies Business Overview
7.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
7.14.5 OraSure Technologies Recent Developments
7.15 Helena Laboratories
7.15.1 Helena Laboratories Comapny Information
7.15.2 Helena Laboratories Business Overview
7.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
7.15.5 Helena Laboratories Recent Developments
7.16 A. Menarini Diagnostics
7.16.1 A. Menarini Diagnostics Comapny Information
7.16.2 A. Menarini Diagnostics Business Overview
7.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
7.16.5 A. Menarini Diagnostics Recent Developments
7.17 Abaxis (Zoetis)
7.17.1 Abaxis (Zoetis) Comapny Information
7.17.2 Abaxis (Zoetis) Business Overview
7.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
7.17.5 Abaxis (Zoetis) Recent Developments
7.18 Ortho Clinical Diagnostics
7.18.1 Ortho Clinical Diagnostics Comapny Information
7.18.2 Ortho Clinical Diagnostics Business Overview
7.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
7.18.5 Ortho Clinical Diagnostics Recent Developments
7.19 Phamatech
7.19.1 Phamatech Comapny Information
7.19.2 Phamatech Business Overview
7.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
7.19.5 Phamatech Recent Developments
7.20 Chembio Diagnostics
7.20.1 Chembio Diagnostics Comapny Information
7.20.2 Chembio Diagnostics Business Overview
7.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
7.20.5 Chembio Diagnostics Recent Developments
7.21 Trinity Biotech
7.21.1 Trinity Biotech Comapny Information
7.21.2 Trinity Biotech Business Overview
7.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
7.21.5 Trinity Biotech Recent Developments
7.22 ELITech Group
7.22.1 ELITech Group Comapny Information
7.22.2 ELITech Group Business Overview
7.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
7.22.5 ELITech Group Recent Developments
7.23 Response Biomedical
7.23.1 Response Biomedical Comapny Information
7.23.2 Response Biomedical Business Overview
7.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
7.23.5 Response Biomedical Recent Developments
7.24 Princeton BioMeditech
7.24.1 Princeton BioMeditech Comapny Information
7.24.2 Princeton BioMeditech Business Overview
7.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
7.24.5 Princeton BioMeditech Recent Developments
7.25 Alfa Wassermann
7.25.1 Alfa Wassermann Comapny Information
7.25.2 Alfa Wassermann Business Overview
7.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
7.25.5 Alfa Wassermann Recent Developments
8 NORTH AMERICA
8.1 North America Point-of-Care Testing (POCT) Market Size by Type
8.1.1 North America Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
8.1.2 North America Point-of-Care Testing (POCT) Sales by Type (2019-2030)
8.1.3 North America Point-of-Care Testing (POCT) Price by Type (2019-2030)
8.2 North America Point-of-Care Testing (POCT) Market Size by Application
8.2.1 North America Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
8.2.2 North America Point-of-Care Testing (POCT) Sales by Application (2019-2030)
8.2.3 North America Point-of-Care Testing (POCT) Price by Application (2019-2030)
8.3 North America Point-of-Care Testing (POCT) Market Size by Country
8.3.1 North America Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Point-of-Care Testing (POCT) Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Point-of-Care Testing (POCT) Market Size by Type
9.1.1 Europe Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
9.1.2 Europe Point-of-Care Testing (POCT) Sales by Type (2019-2030)
9.1.3 Europe Point-of-Care Testing (POCT) Price by Type (2019-2030)
9.2 Europe Point-of-Care Testing (POCT) Market Size by Application
9.2.1 Europe Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
9.2.2 Europe Point-of-Care Testing (POCT) Sales by Application (2019-2030)
9.2.3 Europe Point-of-Care Testing (POCT) Price by Application (2019-2030)
9.3 Europe Point-of-Care Testing (POCT) Market Size by Country
9.3.1 Europe Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Point-of-Care Testing (POCT) Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Point-of-Care Testing (POCT) Market Size by Type
10.1.1 China Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
10.1.2 China Point-of-Care Testing (POCT) Sales by Type (2019-2030)
10.1.3 China Point-of-Care Testing (POCT) Price by Type (2019-2030)
10.2 China Point-of-Care Testing (POCT) Market Size by Application
10.2.1 China Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
10.2.2 China Point-of-Care Testing (POCT) Sales by Application (2019-2030)
10.2.3 China Point-of-Care Testing (POCT) Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Point-of-Care Testing (POCT) Market Size by Type
11.1.1 Asia Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
11.1.2 Asia Point-of-Care Testing (POCT) Sales by Type (2019-2030)
11.1.3 Asia Point-of-Care Testing (POCT) Price by Type (2019-2030)
11.2 Asia Point-of-Care Testing (POCT) Market Size by Application
11.2.1 Asia Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
11.2.2 Asia Point-of-Care Testing (POCT) Sales by Application (2019-2030)
11.2.3 Asia Point-of-Care Testing (POCT) Price by Application (2019-2030)
11.3 Asia Point-of-Care Testing (POCT) Market Size by Country
11.3.1 Asia Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Point-of-Care Testing (POCT) Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Point-of-Care Testing (POCT) Market Size by Type
12.1.1 MEALA Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
12.1.2 MEALA Point-of-Care Testing (POCT) Sales by Type (2019-2030)
12.1.3 MEALA Point-of-Care Testing (POCT) Price by Type (2019-2030)
12.2 MEALA Point-of-Care Testing (POCT) Market Size by Application
12.2.1 MEALA Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
12.2.2 MEALA Point-of-Care Testing (POCT) Sales by Application (2019-2030)
12.2.3 MEALA Point-of-Care Testing (POCT) Price by Application (2019-2030)
12.3 MEALA Point-of-Care Testing (POCT) Market Size by Country
12.3.1 MEALA Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Point-of-Care Testing (POCT) Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Point-of-Care Testing (POCT) Value Chain Analysis
13.1.1 Point-of-Care Testing (POCT) Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Point-of-Care Testing (POCT) Production Mode & Process
13.2 Point-of-Care Testing (POCT) Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Point-of-Care Testing (POCT) Distributors
13.2.3 Point-of-Care Testing (POCT) Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
1.1 Product Definition
1.2 Point-of-Care Testing (POCT) Market by Type
1.2.1 Global Point-of-Care Testing (POCT) Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 Blood Glucose Testing
1.2.3 Infectious Diseases Testing
1.2.4 Cardiac Markers Testing
1.2.5 Coagulation Testing
1.2.6 Pregnancy and Fertility Testing
1.2.7 Blood Gas/Electrolytes Testing
1.2.8 Urinalysis Testing
1.3 Point-of-Care Testing (POCT) Market by Application
1.3.1 Global Point-of-Care Testing (POCT) Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Clinics
1.3.3 Hospitals
1.3.4 Laboratory
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 POINT-OF-CARE TESTING (POCT) MARKET DYNAMICS
2.1 Point-of-Care Testing (POCT) Industry Trends
2.2 Point-of-Care Testing (POCT) Industry Drivers
2.3 Point-of-Care Testing (POCT) Industry Opportunities and Challenges
2.4 Point-of-Care Testing (POCT) Industry Restraints
3 GLOBAL MARKET GROWTH PROSPECTS
3.1 Global Point-of-Care Testing (POCT) Revenue Estimates and Forecasts (2019-2030)
3.2 Global Point-of-Care Testing (POCT) Revenue by Region
3.2.1 Global Point-of-Care Testing (POCT) Revenue by Region: 2019 VS 2023 VS 2030
3.2.2 Global Point-of-Care Testing (POCT) Revenue by Region (2019-2024)
3.2.3 Global Point-of-Care Testing (POCT) Revenue by Region (2025-2030)
3.2.4 Global Point-of-Care Testing (POCT) Revenue Market Share by Region (2019-2030)
3.3 Global Point-of-Care Testing (POCT) Sales Estimates and Forecasts 2019-2030
3.4 Global Point-of-Care Testing (POCT) Sales by Region
3.4.1 Global Point-of-Care Testing (POCT) Sales by Region: 2019 VS 2023 VS 2030
3.4.2 Global Point-of-Care Testing (POCT) Sales by Region (2019-2024)
3.4.3 Global Point-of-Care Testing (POCT) Sales by Region (2025-2030)
3.4.4 Global Point-of-Care Testing (POCT) Sales Market Share by Region (2019-2030)
3.5 US & Canada
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 Middle East, Africa and Latin America
4 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
4.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers
4.1.1 Global Point-of-Care Testing (POCT) Revenue by Manufacturers (2019-2024)
4.1.2 Global Point-of-Care Testing (POCT) Revenue Market Share by Manufacturers (2019-2024)
4.1.3 Global Point-of-Care Testing (POCT) Manufacturers Revenue Share Top 10 and Top 5 in 2023
4.2 Global Point-of-Care Testing (POCT) Sales by Manufacturers
4.2.1 Global Point-of-Care Testing (POCT) Sales by Manufacturers (2019-2024)
4.2.2 Global Point-of-Care Testing (POCT) Sales Market Share by Manufacturers (2019-2024)
4.2.3 Global Point-of-Care Testing (POCT) Manufacturers Sales Share Top 10 and Top 5 in 2023
4.3 Global Point-of-Care Testing (POCT) Sales Price by Manufacturers (2019-2024)
4.4 Global Point-of-Care Testing (POCT) Key Manufacturers Ranking, 2022 VS 2023 VS 2024
4.5 Global Point-of-Care Testing (POCT) Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Point-of-Care Testing (POCT) Manufacturers, Product Type & Application
4.7 Global Point-of-Care Testing (POCT) Manufacturers Commercialization Time
4.8 Market Competitive Analysis
4.8.1 Global Point-of-Care Testing (POCT) Market CR5 and HHI
4.8.2 2023 Point-of-Care Testing (POCT) Tier 1, Tier 2, and Tier
5 POINT-OF-CARE TESTING (POCT) MARKET BY TYPE
5.1 Global Point-of-Care Testing (POCT) Revenue by Type
5.1.1 Global Point-of-Care Testing (POCT) Revenue by Type (2019 VS 2023 VS 2030)
5.1.2 Global Point-of-Care Testing (POCT) Revenue by Type (2019-2030) & (US$ Million)
5.1.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Type (2019-2030)
5.2 Global Point-of-Care Testing (POCT) Sales by Type
5.2.1 Global Point-of-Care Testing (POCT) Sales by Type (2019 VS 2023 VS 2030)
5.2.2 Global Point-of-Care Testing (POCT) Sales by Type (2019-2030) & (M Units)
5.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Type (2019-2030)
5.3 Global Point-of-Care Testing (POCT) Price by Type
6 POINT-OF-CARE TESTING (POCT) MARKET BY APPLICATION
6.1 Global Point-of-Care Testing (POCT) Revenue by Application
6.1.1 Global Point-of-Care Testing (POCT) Revenue by Application (2019 VS 2023 VS 2030)
6.1.2 Global Point-of-Care Testing (POCT) Revenue by Application (2019-2030) & (US$ Million)
6.1.3 Global Point-of-Care Testing (POCT) Revenue Market Share by Application (2019-2030)
6.2 Global Point-of-Care Testing (POCT) Sales by Application
6.2.1 Global Point-of-Care Testing (POCT) Sales by Application (2019 VS 2023 VS 2030)
6.2.2 Global Point-of-Care Testing (POCT) Sales by Application (2019-2030) & (M Units)
6.2.3 Global Point-of-Care Testing (POCT) Sales Market Share by Application (2019-2030)
6.3 Global Point-of-Care Testing (POCT) Price by Application
7 COMPANY PROFILES
7.1 Roche
7.1.1 Roche Comapny Information
7.1.2 Roche Business Overview
7.1.3 Roche Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.1.4 Roche Point-of-Care Testing (POCT) Product Portfolio
7.1.5 Roche Recent Developments
7.2 Abbott
7.2.1 Abbott Comapny Information
7.2.2 Abbott Business Overview
7.2.3 Abbott Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.2.4 Abbott Point-of-Care Testing (POCT) Product Portfolio
7.2.5 Abbott Recent Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Comapny Information
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.3.4 Johnson & Johnson Point-of-Care Testing (POCT) Product Portfolio
7.3.5 Johnson & Johnson Recent Developments
7.4 Siemens Healthcare
7.4.1 Siemens Healthcare Comapny Information
7.4.2 Siemens Healthcare Business Overview
7.4.3 Siemens Healthcare Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.4.4 Siemens Healthcare Point-of-Care Testing (POCT) Product Portfolio
7.4.5 Siemens Healthcare Recent Developments
7.5 Danaher
7.5.1 Danaher Comapny Information
7.5.2 Danaher Business Overview
7.5.3 Danaher Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.5.4 Danaher Point-of-Care Testing (POCT) Product Portfolio
7.5.5 Danaher Recent Developments
7.6 Ascensia
7.6.1 Ascensia Comapny Information
7.6.2 Ascensia Business Overview
7.6.3 Ascensia Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.6.4 Ascensia Point-of-Care Testing (POCT) Product Portfolio
7.6.5 Ascensia Recent Developments
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Comapny Information
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.7.4 Bio-Rad Laboratories Point-of-Care Testing (POCT) Product Portfolio
7.7.5 Bio-Rad Laboratories Recent Developments
7.8 BioMerieux
7.8.1 BioMerieux Comapny Information
7.8.2 BioMerieux Business Overview
7.8.3 BioMerieux Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.8.4 BioMerieux Point-of-Care Testing (POCT) Product Portfolio
7.8.5 BioMerieux Recent Developments
7.9 ARKRAY
7.9.1 ARKRAY Comapny Information
7.9.2 ARKRAY Business Overview
7.9.3 ARKRAY Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.9.4 ARKRAY Point-of-Care Testing (POCT) Product Portfolio
7.9.5 ARKRAY Recent Developments
7.10 Nova Biomedical
7.10.1 Nova Biomedical Comapny Information
7.10.2 Nova Biomedical Business Overview
7.10.3 Nova Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.10.4 Nova Biomedical Point-of-Care Testing (POCT) Product Portfolio
7.10.5 Nova Biomedical Recent Developments
7.11 Trividia Health
7.11.1 Trividia Health Comapny Information
7.11.2 Trividia Health Business Overview
7.11.3 Trividia Health Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.11.4 Trividia Health Point-of-Care Testing (POCT) Product Portfolio
7.11.5 Trividia Health Recent Developments
7.12 Quidel
7.12.1 Quidel Comapny Information
7.12.2 Quidel Business Overview
7.12.3 Quidel Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.12.4 Quidel Point-of-Care Testing (POCT) Product Portfolio
7.12.5 Quidel Recent Developments
7.13 Accriva
7.13.1 Accriva Comapny Information
7.13.2 Accriva Business Overview
7.13.3 Accriva Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.13.4 Accriva Point-of-Care Testing (POCT) Product Portfolio
7.13.5 Accriva Recent Developments
7.14 OraSure Technologies
7.14.1 OraSure Technologies Comapny Information
7.14.2 OraSure Technologies Business Overview
7.14.3 OraSure Technologies Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.14.4 OraSure Technologies Point-of-Care Testing (POCT) Product Portfolio
7.14.5 OraSure Technologies Recent Developments
7.15 Helena Laboratories
7.15.1 Helena Laboratories Comapny Information
7.15.2 Helena Laboratories Business Overview
7.15.3 Helena Laboratories Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.15.4 Helena Laboratories Point-of-Care Testing (POCT) Product Portfolio
7.15.5 Helena Laboratories Recent Developments
7.16 A. Menarini Diagnostics
7.16.1 A. Menarini Diagnostics Comapny Information
7.16.2 A. Menarini Diagnostics Business Overview
7.16.3 A. Menarini Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.16.4 A. Menarini Diagnostics Point-of-Care Testing (POCT) Product Portfolio
7.16.5 A. Menarini Diagnostics Recent Developments
7.17 Abaxis (Zoetis)
7.17.1 Abaxis (Zoetis) Comapny Information
7.17.2 Abaxis (Zoetis) Business Overview
7.17.3 Abaxis (Zoetis) Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.17.4 Abaxis (Zoetis) Point-of-Care Testing (POCT) Product Portfolio
7.17.5 Abaxis (Zoetis) Recent Developments
7.18 Ortho Clinical Diagnostics
7.18.1 Ortho Clinical Diagnostics Comapny Information
7.18.2 Ortho Clinical Diagnostics Business Overview
7.18.3 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.18.4 Ortho Clinical Diagnostics Point-of-Care Testing (POCT) Product Portfolio
7.18.5 Ortho Clinical Diagnostics Recent Developments
7.19 Phamatech
7.19.1 Phamatech Comapny Information
7.19.2 Phamatech Business Overview
7.19.3 Phamatech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.19.4 Phamatech Point-of-Care Testing (POCT) Product Portfolio
7.19.5 Phamatech Recent Developments
7.20 Chembio Diagnostics
7.20.1 Chembio Diagnostics Comapny Information
7.20.2 Chembio Diagnostics Business Overview
7.20.3 Chembio Diagnostics Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.20.4 Chembio Diagnostics Point-of-Care Testing (POCT) Product Portfolio
7.20.5 Chembio Diagnostics Recent Developments
7.21 Trinity Biotech
7.21.1 Trinity Biotech Comapny Information
7.21.2 Trinity Biotech Business Overview
7.21.3 Trinity Biotech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.21.4 Trinity Biotech Point-of-Care Testing (POCT) Product Portfolio
7.21.5 Trinity Biotech Recent Developments
7.22 ELITech Group
7.22.1 ELITech Group Comapny Information
7.22.2 ELITech Group Business Overview
7.22.3 ELITech Group Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.22.4 ELITech Group Point-of-Care Testing (POCT) Product Portfolio
7.22.5 ELITech Group Recent Developments
7.23 Response Biomedical
7.23.1 Response Biomedical Comapny Information
7.23.2 Response Biomedical Business Overview
7.23.3 Response Biomedical Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.23.4 Response Biomedical Point-of-Care Testing (POCT) Product Portfolio
7.23.5 Response Biomedical Recent Developments
7.24 Princeton BioMeditech
7.24.1 Princeton BioMeditech Comapny Information
7.24.2 Princeton BioMeditech Business Overview
7.24.3 Princeton BioMeditech Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.24.4 Princeton BioMeditech Point-of-Care Testing (POCT) Product Portfolio
7.24.5 Princeton BioMeditech Recent Developments
7.25 Alfa Wassermann
7.25.1 Alfa Wassermann Comapny Information
7.25.2 Alfa Wassermann Business Overview
7.25.3 Alfa Wassermann Point-of-Care Testing (POCT) Sales, Revenue, Price and Gross Margin (2019-2024)
7.25.4 Alfa Wassermann Point-of-Care Testing (POCT) Product Portfolio
7.25.5 Alfa Wassermann Recent Developments
8 NORTH AMERICA
8.1 North America Point-of-Care Testing (POCT) Market Size by Type
8.1.1 North America Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
8.1.2 North America Point-of-Care Testing (POCT) Sales by Type (2019-2030)
8.1.3 North America Point-of-Care Testing (POCT) Price by Type (2019-2030)
8.2 North America Point-of-Care Testing (POCT) Market Size by Application
8.2.1 North America Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
8.2.2 North America Point-of-Care Testing (POCT) Sales by Application (2019-2030)
8.2.3 North America Point-of-Care Testing (POCT) Price by Application (2019-2030)
8.3 North America Point-of-Care Testing (POCT) Market Size by Country
8.3.1 North America Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
8.3.2 North America Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
8.3.3 North America Point-of-Care Testing (POCT) Price by Country (2019-2030)
8.3.4 U.S.
8.3.5 Canada
9 EUROPE
9.1 Europe Point-of-Care Testing (POCT) Market Size by Type
9.1.1 Europe Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
9.1.2 Europe Point-of-Care Testing (POCT) Sales by Type (2019-2030)
9.1.3 Europe Point-of-Care Testing (POCT) Price by Type (2019-2030)
9.2 Europe Point-of-Care Testing (POCT) Market Size by Application
9.2.1 Europe Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
9.2.2 Europe Point-of-Care Testing (POCT) Sales by Application (2019-2030)
9.2.3 Europe Point-of-Care Testing (POCT) Price by Application (2019-2030)
9.3 Europe Point-of-Care Testing (POCT) Market Size by Country
9.3.1 Europe Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
9.3.2 Europe Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
9.3.3 Europe Point-of-Care Testing (POCT) Price by Country (2019-2030)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
10 CHINA
10.1 China Point-of-Care Testing (POCT) Market Size by Type
10.1.1 China Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
10.1.2 China Point-of-Care Testing (POCT) Sales by Type (2019-2030)
10.1.3 China Point-of-Care Testing (POCT) Price by Type (2019-2030)
10.2 China Point-of-Care Testing (POCT) Market Size by Application
10.2.1 China Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
10.2.2 China Point-of-Care Testing (POCT) Sales by Application (2019-2030)
10.2.3 China Point-of-Care Testing (POCT) Price by Application (2019-2030)
11 ASIA (EXCLUDING CHINA)
11.1 Asia Point-of-Care Testing (POCT) Market Size by Type
11.1.1 Asia Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
11.1.2 Asia Point-of-Care Testing (POCT) Sales by Type (2019-2030)
11.1.3 Asia Point-of-Care Testing (POCT) Price by Type (2019-2030)
11.2 Asia Point-of-Care Testing (POCT) Market Size by Application
11.2.1 Asia Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
11.2.2 Asia Point-of-Care Testing (POCT) Sales by Application (2019-2030)
11.2.3 Asia Point-of-Care Testing (POCT) Price by Application (2019-2030)
11.3 Asia Point-of-Care Testing (POCT) Market Size by Country
11.3.1 Asia Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
11.3.2 Asia Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
11.3.3 Asia Point-of-Care Testing (POCT) Price by Country (2019-2030)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 China Taiwan
11.3.9 Southeast Asia
12 MIDDLE EAST, AFRICA AND LATIN AMERICA
12.1 MEALA Point-of-Care Testing (POCT) Market Size by Type
12.1.1 MEALA Point-of-Care Testing (POCT) Revenue by Type (2019-2030)
12.1.2 MEALA Point-of-Care Testing (POCT) Sales by Type (2019-2030)
12.1.3 MEALA Point-of-Care Testing (POCT) Price by Type (2019-2030)
12.2 MEALA Point-of-Care Testing (POCT) Market Size by Application
12.2.1 MEALA Point-of-Care Testing (POCT) Revenue by Application (2019-2030)
12.2.2 MEALA Point-of-Care Testing (POCT) Sales by Application (2019-2030)
12.2.3 MEALA Point-of-Care Testing (POCT) Price by Application (2019-2030)
12.3 MEALA Point-of-Care Testing (POCT) Market Size by Country
12.3.1 MEALA Point-of-Care Testing (POCT) Revenue Grow Rate by Country (2019 VS 2023 VS 2030)
12.3.2 MEALA Point-of-Care Testing (POCT) Sales by Country (2019 VS 2023 VS 2030)
12.3.3 MEALA Point-of-Care Testing (POCT) Price by Country (2019-2030)
12.3.4 Mexico
12.3.5 Brazil
12.3.6 Israel
12.3.7 Argentina
12.3.8 Colombia
12.3.9 Turkey
12.3.10 Saudi Arabia
12.3.11 UAE
13 VALUE CHAIN AND SALES CHANNELS ANALYSIS
13.1 Point-of-Care Testing (POCT) Value Chain Analysis
13.1.1 Point-of-Care Testing (POCT) Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Point-of-Care Testing (POCT) Production Mode & Process
13.2 Point-of-Care Testing (POCT) Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Point-of-Care Testing (POCT) Distributors
13.2.3 Point-of-Care Testing (POCT) Customers
14 CONCLUDING INSIGHTS
15 APPENDIX
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
